Uncategorized

Vancouver, British Columbia, December 2, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), is pleased to announce that the Company has entered into a Subscription Agreement with Philippine Metals Inc. (“PHI”) to invest up to $200,000 in Subscription Receipts.  PHI, a TSX Venture Exchange listed issuer, is currently

Vancouver, British Columbia, November 5, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) announces that it has filed Notice of an Extraordinary Meeting of Debentureholders to be held November 30, 2021 (the “Meeting”).  At the Meeting, debentureholders (the “Debentureholders”) will be asked to consider and, if deemed appropriate,

Vancouver, British Columbia, July 13th, 2021– Chemistree Technology Inc. (CSE: CHM and CHM.wt) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company Immunoflex Therapeutics Inc. (“ImmunoFlex”™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The exploratory trial was the